Mild serotonin syndrome: A report of 12 cases

Annals of Indian Academy of Neurology

Volumn 18, Issue 2, 2015, Pages 226-230

  Prakash, Sanjay ^a   Patel, Varsha ^a   Kakked, Siddharth ^a   Patel, Indravadan ^a,b   Yadav, Rahul ^a,b  

^a Smt Bhikhiben Kantilal Shah Medical Institute and Research Centre Piperia   (India)

^b Baroda Medical College   (India)

Author keywords

Antidepressant; clonus; cyproheptadine; drug toxicity; selective serotonin reuptake inhibitors; serotonin syndrome; tremor

Indexed keywords

CHLORPHENIRAMINE; CYPROHEPTADINE; DEXTROMETHORPHAN; FLUOXETINE; HERBACEOUS AGENT; PAROXETINE; SEROTONIN AGONIST; VALPROIC ACID; VENLAFAXINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CLONUS; DISEASE SEVERITY; DIZZINESS; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; HYPERREFLEXIA; MALE; MIDDLE AGED; MUSCLE HYPERTONIA; PAIN; SEIZURE; SEROTONIN SYNDROME; TREATMENT RESPONSE; TREMOR; YOUNG ADULT;

EID: 84929615012     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.150612     Document Type: Article

References (17)

1. Boyer EW, Shanon M. The serotonin syndrome. N Engl J Med 2005;352:1112-20.
2. Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: Simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003;96:635-42.
3. Radomski JW, Dursun SM, Reveley MA, Kutcher SP. An exploratory approach to the serotonin syndrome: An update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses 2000;55:218-24.
4. Bartlett D. Serotonin syndrome: A subtle toxicity. J Emerg Nors 2006;32:277-9.
5. Lejoyeux M, Rouilon F, Ades J. Prospective evaluation of the serotonin syndrome in depressed in patients treated with clomipramine. Acta Psychiatr Scand 1993;88:369-71.
6. Kaneda Y, Ishimoto Y, Ohmori T. Mild serotonin syndrome on fluvoxamine. Int J Neurosci 2001;109:165-72.
7. Mackay FJ, Dunn NR, Mann RD. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract 1999;49:871-4.
8. Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004;42:277-85.
9. Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ 2014;348:g1626.
10. Edwards JG, Anderson I. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs 1999;57:507-33.
11. Alnwick GM. Misdiagnosis of serotonin syndrome as fibromyalgia and the role of physical therapists. Phys Ther 2008;88:757-65.
12. Prakash S, Belani P, Trivedi A. Headache as a presenting feature in patients with serotonin syndrome: A case series. Cephalalgia 2014;34:148-53.
13. Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: A practical approach to diagnosis and treatment. Med J Aust 2007;187 361-5.
14. Isbister GK, Hackett LP, Dawson AH, Whyte IM, Smith AJ. Moclobemide poisoning: Toxicokinetics and occurrence of serotonin toxicity. Br J Clin Pharmacol 2003;56:441-50.
15. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705-13.
16. Ganetsky M, Brush E. Serotonin syndrome - What have we learned? Clin Pediatr Emerg Med 2005;6:103.
17. Lamberg JJ, Gordin VN. Serotonin syndrome in a patient with chronic pain polypharmacy. Pain Med 2014;15:1429-31.